title: Endothelial function improves within 6 weeks of treatment with methotrexate or methotrexate in combination with a TNF-α inhibitor in rheumatoid arthritis patients.
authors.forename: G
authors.initials: G
authors.lastname: Hjeltnes
authors.forename: I
authors.initials: I
authors.lastname: Hollan
authors.forename: Ø
authors.initials: Ø
authors.lastname: Førre
authors.forename: A
authors.initials: A
authors.lastname: Wiik
authors.forename: T
authors.initials: T
authors.lastname: Lyberg
authors.forename: K
authors.initials: K
authors.lastname: Mikkelsen
authors.forename: S
authors.initials: S
authors.lastname: Agewall
mesh_terms: D000368:Aged; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000503:physiopathology; D004359:Drug Therapy, Combination; D004730:Endothelium, Vascular / Q000187:drug effects / Q000503:physiopathology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage*; D008875:Middle Aged; D010991:Plethysmography; D011446:Prospective Studies; D012720:Severity of Illness Index; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage* / Q000037:antagonists & inhibitors
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D008727:Methotrexate